MARKET

BIVIW

BIVIW

Biovie Inc
NASDAQ
0.4400
+0.0100
+2.33%
Closed 15:42 06/29 EDT
OPEN
0.4300
PREV CLOSE
0.4300
HIGH
0.4400
LOW
0.4300
VOLUME
1.00K
TURNOVER
--
52 WEEK HIGH
0.5200
52 WEEK LOW
0.1650
MARKET CAP
--
P/E (TTM)
-0.1017
1D
5D
1M
3M
1Y
5Y
1D
BIOVIE - FILES TO OFFER UP TO $300 MLN IN SECURITIES - SEC FILING
Reuters · 06/18 21:22
BioVie posts corporate presentation spotlighting bezisterim longevity-focused therapy pipeline
PUBT · 06/02 14:20
BioVie to host live investor webinar with CEO presentation and Q&A
PUBT · 05/27 12:03
BioVie completes enrollment in Phase 2 long COVID trial of bezisterim, targets late summer 2026 data
PUBT · 05/26 12:06
BIOVIE ANNOUNCES FULL ENROLLMENT OF THE ADDRESS-LC TRIAL OF BEZISTERIM FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS ASSOCIATED WITH LONG COVID
Reuters · 05/26 12:00
BioVie completes Phase 2 SUNRISE-PD trial of bezisterim in early Parkinson’s disease
PUBT · 05/18 12:04
BIOVIE ANNOUNCES COMPLETION OF PHASE 2 SUNRISE-PD TRIAL IN EARLY-STAGE PARKINSON’S DISEASE
Reuters · 05/18 12:00
BioVie Q3 FY26 net loss widens to $5.3 million; operating expenses climb to $5.4 million
PUBT · 05/11 20:57
More

Webull offers Biovie Inc stock information, including NASDAQ: BIVIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIVIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIVIW stock methods without spending real money on the virtual paper trading platform.